{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:55:58Z","timestamp":1790751358826,"version":"4.1.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>\n                    This study aimed to evaluate the frequency, indications, pre-transfusion threshold values, associated risk factors, and complications of blood product transfusions in pediatric oncology patients to contribute to the development of evidence-based, standardized transfusion strategies. This single-center, prospective observational study included 41 pediatric oncology patients aged 1 to 18 years who received red blood cell (RBC), platelet, or fresh frozen plasma (FFP) transfusions between June 2023 and June 2024. Patients were followed throughout their treatment and for six months after their final transfusion. Among 404 transfusions (215 RBC, 183 platelet, 6 FFP), the mean number per patient was 9.78\u2009\u00b1\u20099.2. Pre-transfusion platelet thresholds were significantly higher in the leukemia\/lymphoma group than in the solid tumor group (23,892\u2009\u00b1\u200911,773\/mm\n                    <jats:sup>3<\/jats:sup>\n                    vs. 16,669\u2009\u00b1\u200911,921\/mm\n                    <jats:sup>3<\/jats:sup>\n                    ;\n                    <jats:italic>p<\/jats:italic>\n                    &amp;lt; 0.001), while RBC hemoglobin thresholds were similar (7.4\u2009\u00b1\u20090.6 vs. 7.3\u2009\u00b1\u20090.8 g\/dL;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.67). Advanced-stage disease (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.04) and relapsed or refractory disease (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.026) were associated with increased RBC transfusion requirements. Acute reactions occurred in 12.4% of transfusions, most (84%) being febrile nonhemolytic reactions. Premedication did not prevent reactions (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.6). During long-term follow-up, serum ferritin exceeded 1000 ng\/mL in 45.7% of patients. Transfusion management varies by diagnosis, with platelet thresholds in hematologic malignancies maintained higher than literature recommended. Advanced-stage and relapsed or refractory disease increase the transfusion burden. The high incidence of acute reactions and iron overload underscores the need for transfusion safety, long-term monitoring, and standardized, evidence-based transfusion strategies in pediatric oncology.\n                  <\/jats:p>","DOI":"10.3389\/fped.2026.1955442","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:02:16Z","timestamp":1790748136000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Transfusion practices, thresholds, and complications in pediatric oncology patients: a single-center prospective longitudinal observational study"],"prefix":"10.3389","volume":"14","author":[{"given":"B\u00fc\u015fra","family":"Tunal\u0131 \u00d6zcan","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Ankara University Faculty of Medicine","place":["Ankara, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonay","family":"\u0130ncesoy \u00d6zdemir","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Oncology, Ankara University Faculty of Medicine","place":["Ankara, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Handan","family":"Din\u00e7aslan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Oncology, Ankara University Faculty of Medicine","place":["Ankara, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihal","family":"Ekin Da\u011f","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Oncology, Ankara University Faculty of Medicine","place":["Ankara, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cem","family":"\u00c7anak\u00e7i","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Oncology, Ankara University Faculty of Medicine","place":["Ankara, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vafa","family":"Maharramova","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Oncology, Ankara University Faculty of Medicine","place":["Ankara, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00fcbar","family":"Mustafayeva","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Oncology, Ankara University Faculty of Medicine","place":["Ankara, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emel","family":"\u00dcnal","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Oncology, Ankara University Faculty of Medicine","place":["Ankara, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurdan","family":"Ta\u00e7y\u0131ld\u0131z","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Oncology, Ankara University Faculty of Medicine","place":["Ankara, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1016\/j.ejca.2006.05.006","article-title":"Trends in survival after childhood cancer in Europe, 1978\u20131997: report from the automated childhood cancer information system project (ACCIS)","volume":"42","author":"Magnani","year":"2006","journal-title":"Eur J Cancer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1111\/trf.12677","article-title":"An epidemiologic cohort study reviewing the practice of blood product transfusions among a population of pediatric oncology patients","volume":"54","author":"Lieberman","year":"2014","journal-title":"Transfusion"},{"key":"B3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1634\/theoncologist.2011-S3-12","article-title":"Management of anemia in cancer patients: transfusions","volume":"16","author":"Schrijvers","year":"2011","journal-title":"Oncologist"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1111\/trf.16626","article-title":"Transfusion practices for pediatric oncology and hematopoietic stem cell transplantation patients: data from the national heart lung and blood institute recipient epidemiology and donor evaluation study-III (REDS-III)","volume":"61","author":"Goel","year":"2021","journal-title":"Transfusion"},{"key":"B5","doi-asserted-by":"publisher","first-page":"924","DOI":"10.55730\/1300-0144.5869","article-title":"Blood component-associated acute transfusion reactions in pediatric patients: experience of a tertiary care hospital","volume":"54","author":"Guzelkucuk","year":"2024","journal-title":"Turk J Med Sci"},{"key":"B6","doi-asserted-by":"publisher","first-page":"370","DOI":"10.4103\/0253-7613.161257","article-title":"Study of acute transfusion reactions in a teaching hospital of Sikkim: a hemovigilance initiative","volume":"47","author":"Sharma","year":"2015","journal-title":"Indian J Pharmacol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1537-2995.2007.01484.x","article-title":"Blood transfusions in children: a multi-institutional analysis of practices and complications","volume":"48","author":"Slonim","year":"2008","journal-title":"Transfusion"},{"key":"B8","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.hoc.2016.01.010","article-title":"Transfusion considerations in pediatric hematology and oncology patients","volume":"30","author":"Bercovitz","year":"2016","journal-title":"Hematol Oncol Clin North Am"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1097\/CCM.0000000000003192","article-title":"Platelet transfusion practices in critically ill children","volume":"46","author":"Nellis","year":"2018","journal-title":"Crit Care Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.hoc.2019.05.011","article-title":"Transfusion management in pediatric oncology patients","volume":"33","author":"Nellis","year":"2019","journal-title":"Hematol Oncol Clin North Am"},{"key":"B11","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1067\/mpd.2003.14","article-title":"Pediatric red blood cell transfusions increase resource use","volume":"142","author":"Goodman","year":"2003","journal-title":"J Pediatr"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1016\/S0959-8049(01)00324-0","article-title":"Rational use of blood products","volume":"37","author":"Solheim","year":"2001","journal-title":"Eur J Cancer"},{"key":"B13","year":"2020"},{"key":"B14","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1097\/00062752-199911000-00012","article-title":"Pathophysiology of febrile nonhemolytic transfusion reactions","volume":"6","author":"Heddle","year":"1999","journal-title":"Curr Opin Hematol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1213\/ane.0b013e3181930a6e","article-title":"Noninfectious serious hazards of transfusion","volume":"108","author":"Hendrickson","year":"2009","journal-title":"Anesth Analg"},{"key":"B16","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/bjh.12150","article-title":"Current understanding of allergic transfusion reactions: incidence, pathogenesis, laboratory tests, prevention and treatment","volume":"160","author":"Hirayama","year":"2013","journal-title":"Br J Haematol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"300","DOI":"10.4045\/tidsskr.11.1211","article-title":"[Palatal myoclonus]","volume":"132","author":"Alstadhaug","year":"2012","journal-title":"Tidsskr Nor Laegeforen"},{"key":"B18","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/ALN.0b013e31822a22d9","article-title":"Reducing noninfectious risks of blood transfusion","volume":"115","author":"Gilliss","year":"2011","journal-title":"Anesthesiology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1200\/JCO.2017.76.1734","article-title":"Platelet transfusion for patients with cancer: American Society of Clinical Oncology clinical practice guideline update","volume":"36","author":"Schiffer","year":"2018","journal-title":"J Clin Oncol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1200\/JCO.2001.19.5.1519","article-title":"Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology","volume":"19","author":"Schiffer","year":"2001","journal-title":"J Clin Oncol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1111\/j.1365-2141.2005.05670.x","article-title":"Premedication with acetaminophen or diphenhydramine for transfusion with leucoreduced blood products in children","volume":"130","author":"Sanders","year":"2005","journal-title":"Br J Haematol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e30664","DOI":"10.1002\/pbc.30664","article-title":"The feasibility of implementing Toronto childhood cancer stage guidelines and estimating the impact on outcome for childhood cancers in seven pediatric oncology units in sub-Saharan Africa. A study from the Franco-African Pediatric Oncology Group","volume":"70","author":"Mallon","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"B23","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/bjh.14423","article-title":"Guidelines for the use of platelet transfusions","volume":"176","author":"Estcourt","year":"2017","journal-title":"Br J Haematol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1056\/NEJMoa1212772","article-title":"A no-prophylaxis platelet-transfusion strategy for hematologic cancers","volume":"368","author":"Stanworth","year":"2013","journal-title":"N Engl J Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"S98","DOI":"10.1097\/PCC.0000000000001590","article-title":"Recommendations on RBC transfusion in general critically ill children based on hemoglobin and\/or physiologic thresholds from the pediatric critical care transfusion and anemia expertise initiative","volume":"19","author":"Doctor","year":"2018","journal-title":"Pediatr Crit Care Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.bbmt.2011.10.043","article-title":"Impact of a conservative red blood cell transfusion strategy in children undergoing hematopoietic stem cell transplantation","volume":"18","author":"Lightdale","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"B27","doi-asserted-by":"publisher","first-page":"S149","DOI":"10.1097\/PCC.0000000000001610","article-title":"Recommendations on RBC transfusion support in children with hematologic and oncologic diagnoses from the pediatric critical care transfusion and anemia expertise initiative","volume":"19","author":"Steiner","year":"2018","journal-title":"Pediatr Crit Care Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/vox.12833","article-title":"Analysis of clinical presentations of allergic transfusion reactions and febrile non-haemolytic transfusion reactions in paediatric patients","volume":"114","author":"Yanagisawa","year":"2019","journal-title":"Vox Sang"},{"key":"B29","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.tracli.2013.09.002","article-title":"[Allergic adverse transfusion reactions in paediatrics, a 3-year study]","volume":"20","author":"Moncharmont","year":"2013","journal-title":"Transfus Clin Biol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/tme.12502","article-title":"Serious hazards of transfusion - conference report: celebration of 20 years of UK haemovigilance","volume":"27","author":"Bolton-Maggs","year":"2017","journal-title":"Transfus Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tmrv.2006.09.001","article-title":"Acetaminophen and diphenhydramine premedication for allergic and febrile nonhemolytic transfusion reactions: good prophylaxis or bad practice?","volume":"21","author":"Geiger","year":"2007","journal-title":"Transfus Med Rev"},{"key":"B32","author":"Porter","year":"2025"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1955442\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:02:17Z","timestamp":1790748137000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1955442\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":32,"alternative-id":["10.3389\/fped.2026.1955442"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1955442","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"article-number":"1955442"}}